The Cystic Fibrosis Airway Milieu Enhances Rescue of F508del in a Pre-Clinical Model

Ítems similars

• Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia
  per: Tomati, Valeria, et al.
  Publicat: (2018)
• Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epithelia
  per: Tomati, Valeria, et al.
  Publicat: (2019)
• Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation
  per: Cholon, Deborah M., et al.
  Publicat: (2016)
• Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
  per: Gentzsch, Martina, et al.
  Publicat: (2021)
• Potentiator Ivacaftor Abrogates Pharmacological Correction of ΔF508 CFTR in Cystic Fibrosis
  per: Cholon, Deborah M., et al.
  Publicat: (2014)